A carregar...

Benefit of pre-emptive pharmacogenetic information on clinical outcome

The development of new knowledge around the genetic determinants of variable drug action has naturally raised the question of how this new knowledge can be used to improve the outcome of drug therapy. Two broad approaches have been taken: a point-of-care approach in which genotyping for specific var...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pharmacol Ther
Main Authors: Roden, Dan M., Van Driest, Sara L., Mosley, Jonathan D., Wells, Quinn S., Robinson, Jamie R., Denny, Joshua C., Peterson, Josh F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134843/
https://ncbi.nlm.nih.gov/pubmed/29377064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!